Clinical Trial Detail

NCT ID NCT02494921
Title LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC
Recruitment Active, not recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Rahul Aggarwal
Indications

prostate cancer

Therapies

Docetaxel + Filgrastim + Prednisone + Ribociclib

Age Groups: adult

No variant requirements are available.